Pollen Forecast 07981 :

Pollen Forecast 07981 :


The Clear Choice of Claritin®: Non-drowsy Allergy Relief1








*As demonstrated in a clinical trial, based on peak intake after the first dose vs fluticasone propionate 50 mcg nasal spray (2 sprays per nostril).

Nose icon showing airflow - improves nasal airflow 2x more


#1 Doctor Recommended

Claritin® is the #1 doctor recommended OTC brand of non-drowsy adult oral antihistamines12

#1 worldwide icon

Claritin® is the global #1 OTC non-drowsy allergy remedy12

Clinically proven icon

Approximately 90,000 subjects aged 12 years and older have been treated with loratadine (10 mg, once daily) in controlled and uncontrolled clinical trials14


Claritin® offers allergy relief for kids and adults in a variety of forms and flavors.

Help your patients tackle their tough allergy symptoms with samples and coupons for Claritin® products.

several versions of Claritin products neatly arranged

References: 1. Claritin® Drug Facts. NDA019658. 2. Ramaekers JG, Uiterwijk MMC, O’Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42(4):363-369. 3. Verster JC, Volkerts ER.  Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004;92(3):294-303. doi:10.1016/S1081-1206(10)61566-9 4. Popescu F-D. H1 antihistamines and driving. J Med Life. 2008;1(3):262-268. 5. Federal Aviation Administration. What over-the-counter (OTC) medications can I take and still be safe to fly? Accessed August 4, 2021. https://www.faa.gov/licenses_certificates/medical_certification/media/OTCMedicationsforPilots.pdf 6. Kay GG, Harris AG. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy. 1999;29 Suppl 3:147-150. doi:10.1046/j.1365-2222.1999.0290s3147.x 7. Kaiser HB, Gopalan G, Chung W. Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy Asthma Proc. 2008;29:654-658. 8. Philip G, Malstrom K, Hampel Jr. FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002;32(7):1020-1028. 9. Claritin-D® 12 Hour Drug Facts. NDA019670. 10. Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Ann Allergy Asthma lmmunol. 2000;84(4):451-459. 11. Children’s Claritin® Chewables Drug Facts. NDA021891. 12. Data on file. Bayer Pharmaceuticals. CLARITIN refers to CLARITIN and all CLAR-brand variations. 13. Ng CC, Romaikin D, Steacy LM, et al. Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis. Ann Allergy Asthma Immunol. 2021;S1081-1206(21)00348-3. doi:10.1016/j.anai.2021.05.001 14. Claritin®. Prescribing information. Schering Corporation; 2000.